Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

[1]  K. Gelmon,et al.  ESO-ESMO 4rd International Consensus Guidelines for Breast Cancer in Young Women (BCY4). , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  S. Tin Tin,et al.  Geographic variations in surgical treatment for breast cancer: a systematic review , 2020 .

[3]  G. Defossez,et al.  Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France , 2019, PloS one.

[4]  A. Goldhirsch,et al.  Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers. , 2019, Breast.

[5]  E. Winer,et al.  Estimating the Benefits of Therapy for Early Stage Breast Cancer The St Gallen International Consensus Guidelines for the Primary Therapy of Early Breast Cancer 2019. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  M. Fouad,et al.  Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials , 2019, Cancer.

[7]  Yeon-Hee Park,et al.  Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression , 2019, Breast Cancer Research and Treatment.

[8]  L. Trevena,et al.  Culture, Self, and Medical Decision Making in Australia and China: A Structural Model Analysis , 2019, MDM policy & practice.

[9]  I. Voutsadakis,et al.  The Oncotype Dx Assay in ER-Positive, HER2-Negative Breast Cancer Patients: A Real Life Experience from a Single Cancer Center. , 2019, European journal of breast health.

[10]  M. Somerfield,et al.  Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M. Regan,et al.  Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and Shadows. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Qijun Wu,et al.  Assessment of the development of assisted reproductive technology in Liaoning province of China, from 2012 to 2016 , 2018, BMC Health Services Research.

[13]  E. Winer,et al.  Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer , 2018, The New England journal of medicine.

[14]  R. Gelber,et al.  Estimation of historical control rate for a single arm de-escalation study: Application to the POSITIVE trial. , 2018 .

[15]  S. Loibl,et al.  The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients. , 2018, Breast.

[16]  M. Ignatiadis,et al.  Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status. , 2018, Journal of the National Cancer Institute.

[17]  M. Tan,et al.  Addressing the paradox of increasing mastectomy rates in an era of de-escalation of therapy: Communication strategies. , 2018, Breast.

[18]  N. Suzuki.  Clinical Practice Guidelines for Fertility Preservation in Pediatric, Adolescent, and Young Adults with Cancer , 2018, International Journal of Clinical Oncology.

[19]  Ian Krop,et al.  Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  F. Clatot,et al.  Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the art , 2017, Current opinion in oncology.

[21]  M. Kerin,et al.  Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer , 2017, Breast cancer.

[22]  R. Winterhalder,et al.  Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10) , 2017, BMC Cancer.

[23]  Y. Choi,et al.  The status of assisted reproductive technology in Korea in 2012 , 2017, Clinical and experimental reproductive medicine.

[24]  David F. Albertini,et al.  Systematic review of worldwide trends in assisted reproductive technology 2004–2013 , 2017, Reproductive Biology and Endocrinology.

[25]  T. Yau,et al.  The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong. , 2016, Clinical breast cancer.

[26]  Rulla M Tamimi,et al.  Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  A. Eisen,et al.  Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Yu Xie,et al.  Marriage and Family in East Asia: Continuity and Change. , 2015, Annual review of sociology.

[29]  R. Gelber,et al.  Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? , 2015, Breast.

[30]  A. Giobbie-Hurder,et al.  Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. , 2014, The New England journal of medicine.

[31]  R. Tamimi,et al.  Prospective study of fertility concerns and preservation strategies in young women with breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  H. Gómez,et al.  Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3‐98 , 2014, Psycho-oncology.

[33]  E. Perez,et al.  Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  E. Winer,et al.  Web-based survey of fertility issues in young women with breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.